New Owner
GSK (GlaxoSmithKline) - Human Genome Sciences
GSK (GlaxoSmithKline) acquires Human Genome Sciences
Announced: August 03, 2012
Type: Acquisition
Status: Pending
Amount: $ 3,000,000,000